[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370066-105":59,"doc-detail-370066-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cxcr3-gene-as-a-therapeutic-target-in-colorectal-cancer","CXCR3 gene as a therapeutic target in colorectal cancer","","Colorectal cancer remains among the most common and lethal malignancies, while conventional treatments such as chemotherapy, surgery, and immunotherapy often introduce significant side effects. This study evaluates whether targeting the CXCR3 gene can impair colorectal cancer cell growth. Gene-specific DNAzymes were used to downregulate CXCR3 in HCT-116 cells, followed by analyses including cell-cycle assessment, Annexin V-PI staining, and wound-healing assays. CXCR3 suppression inhibited AKT–mTOR signaling and reduced proliferation while increasing apoptosis, supporting CXCR3 as a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cxcr3-gene-as-a-therapeutic-target-in-colorectal-cancer/370066/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cxcr3-gene-as-a-therapeutic-target-in-colorectal-cancer/370066.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study aiming to determine about CXCR3 in colorectal cancer?","Question",{"text":112,"@type":113},"The study investigates how targeting and downregulating the CXCR3 gene affects the development of colorectal cancer cells, specifically HCT-116.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CXCR3 downregulation performed and what key assays were used?",{"text":117,"@type":113},"Gene-specific DNAzymes were designed to downregulate CXCR3, and effects were evaluated using cell cycle analysis, Annexin V-PI staining, and a wound healing method.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings after CXCR3 downregulation?",{"text":121,"@type":113},"CXCR3 gene downregulation inhibited the AKT–mTOR pathway and reduced proliferation and growth of HCT-116 cells, while increasing apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370066,1791134043,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Azarshin etal. BMC Cancer (2026) 26:80 [https://doi.org/10.1186/s12885-025-15409-w](https://doi.org/10.1186/s12885-025-15409-w)  \nBMC Cancer  \nRESEARCH Open Access  \nCXCR3 gene as a therapeutic target in colorectal cancer  \nSeyedeh Zohreh Azarshin 1†, Melina Mal mir 1†, Seyedeh Fatemeh Sajjadi 1 and Mehrdad Behmanesh 1*  \nAbstract  \nBackground Cancers, especially colorectal cancer, are among the most common and deadly diseases in the world, and their incidence is increasing in various countries. Current therapeutic methods, such as chemotherapy, surgery, and immunotherapy, have failed to provide successful treatment without side effects. Therefore, identifying effective therapeutic targets is crucial. Several studies have demonstrated that the expression of the CXCR3 gene, a member of the GPCR family, is elevated in colorectal cancer.  \nMethods In this study, the effect of targeting the CXCR3 gene on the HCT-116 line, a colorectal cancer cell line, was investigated via gene-specific targeting. For this purpose, specific DNAzymes were designed, and the impact of CXCR3 downregulation on cancer cell development was assessed via cell cycle analysis, Annexin V-PI staining, and the wound healing method.  \nResults CXCR3 gene downregulation inhibited the key AKT‒MTOR pathway and reduced proliferation and growth of HCT-116 cells. Moreover, CXCR3 mRNA downregulation increased the apoptosis of these cells.  \nConclusion Our findings suggest that downregulation of CXCR3 mRNA inhibits colorectal cancer cell growth through inhibition of the AKT‒mTOR pathway. The CXCR3 receptor can be considered a new therapeutic target in colorectal cancer therapy.  \nKeywords Gene therapy, GPCR, CXCR3, Colorectal cancer, Gene targeting  \nIntroduction  \nAccording to the World Health Organization (WHO), a significant increase in deaths from colorectal cancer (CRC) and rectal cancer is predicted to occur up to 2035 [1]. CRC is the third most common cancer worldwide, and it is also the second most common cause of cancer death (8–9% of cancer-related deaths) [2, 3]. More than  \n†Seyedeh Zohreh Azarshin and Melina Mal mir contributed equally to this work.  \n*Correspondence: Mehrdad Behmanesh [behmanesh@modares.ac.ir](behmanesh@modares.ac.ir)  \n1Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, P. O. Box: 14115-154, Tehran, Iran  \n90% of deaths from cancer are in the metastasis stage [1]. Current therapeutic strategies are based on surgery followed by chemotherapy, radiation therapies, and immunotherapy, all of which have side effects that often significantly impact quality of life. Currently, novel targeted strategies are being developed to improve the efficacy and reduce the toxicity of conventional treatments [4].  \nG protein-coupled receptors (GPCRs) constitute the largest family of cell surface receptors and play important roles in transmitting signals into the cell. GPCRshave a key impact on many processes, such as proliferation, migration, and cell survival [5]. Therefore, GPCRshave become potential targets for the treatment of many disorders, such as high blood pressure, diabetes,  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or","cbCaicNgz9YEilta","https://ap.wps.com/l/cbCaicNgz9YEilta","pdf",2409184,"English","# Abstract\n# Introduction\n## Colorectal cancer burden and treatment limitations\n## Role of GPCRs and CXCR3 in cancer biology\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the study aiming to determine about CXCR3 in colorectal cancer?\",\"answer\":\"The study investigates how targeting and downregulating the CXCR3 gene affects the development of colorectal cancer cells, specifically HCT-116.\"},{\"question\":\"How was CXCR3 downregulation performed and what key assays were used?\",\"answer\":\"Gene-specific DNAzymes were designed to downregulate CXCR3, and effects were evaluated using cell cycle analysis, Annexin V-PI staining, and a wound healing method.\"},{\"question\":\"What were the main findings after CXCR3 downregulation?\",\"answer\":\"CXCR3 gene downregulation inhibited the AKT–mTOR pathway and reduced proliferation and growth of HCT-116 cells, while increasing apoptosis.\"}]","CXCR3 gene as a therapeutic target in colorectal cancer | PDF",1790186560,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae6c6f1d269008b971f04748b192195c.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3351c2ed33aa7ed9d032f484fc7907bb.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a474c0e37e622094ed2e98928e17948.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a6b654df9688a94f0181aef3de64865.webp",980,1306]